Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.50
Bid: 175.00
Ask: 190.00
Change: 0.00 (0.00%)
Spread: 15.00 (8.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Coex Services Asia

24 Jun 2013 07:00

RNS Number : 6649H
Synectics PLC
24 June 2013
 



For immediate release

24 June 2013

 

 

 

Synectics plc

("Synectics" or the "Company")

 

Acquisition of Coex Services Asia

 

Synectics plc (AIM: SNX), a leader in the design, integration and control of advanced surveillance technology and networked security systems, is pleased to announce that it has acquired the balance of the share capital in Coex Services Asia Pte Ltd ("CSA") for a maximum consideration of up to £2.1 million.

 

CSA is a private Singaporean company supplying surveillance systems in the Far East, primarily to the Oil & Gas sector. In its audited results for the year ended 31 December 2012, CSA reported profit before tax of £0.2 million on revenue of £2.4 million, and net assets of £0.9 million. The Group have held a 20% interest in CSA since 2004.

 

The Singapore subsidiary of Synectics plc, Synectic Systems (Asia) Pte Limited, has acquired the remaining 80% of share capital in CSA for an initial consideration of £1.8 million, comprising £1.3 million in cash, 101,403 Ordinary Shares in Synectics plc (valued at £0.4 million on 31 May 2013), and the transfer of the Group's 20% interest in a related company valued at £0.1 million. CSA currently has net assets of approximately £1.1 million and holds net cash of around £0.9 million. In addition, further consideration of up to £0.3 million will be payable in cash dependent on the profit performance of CSA in the two years following acquisition.

 

Under the terms of the acquisition the CSA directors, and previous principal shareholders, Kenny Tan (Managing Director) and Veronica Chua (Finance Director) will remain with CSA for a minimum period of three years.

 

Commenting on the acquisition, John Shepherd Chief Executive of Synectics said:

"Development of our business in the Far East is a significant part of our strategy, and so we are delighted to bring CSA fully into the Group and secure the services of Kenny Tan and Veronica Chua to expand our operational hub in Singapore."

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

John Shepherd, Chief Executive

Email: info@synecticsplc.com

www.synecticsplc.com

 

Westhouse Securities Limited

Tel: +44 (0) 207 601 6100

Tom Griffiths

 Media enquiries:

Buchanan

Tel: +44 (0) 207 466 5000

Mark Court / Fiona Henson / Sophie Cowles

Email: synectics@buchanan.uk.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBIGDLSSDBGXX
Date   Source Headline
16th Jun 20097:00 amRNSStructural and Strategic Reorganisation
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.